Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step.

JAMA ·Vol. 292 ·No. 23 ·2004-12-15 ·Pages 2909-13

Manns MP, Wedemeyer H

Abstract

暂无摘要

MeSH Terms

Antiretroviral Therapy, Highly Active Antiviral Agents/therapeutic use HIV Infections/complications,drug therapy Hepacivirus/genetics Hepatitis C, Chronic/complications,drug therapy Humans Interferon alpha-2 Interferon-alpha/therapeutic use Polyethylene Glycols Recombinant Proteins Ribavirin/therapeutic use Viral Load

Chemicals

Antiviral Agents Interferon alpha-2 Interferon-alpha Recombinant Proteins Polyethylene Glycols Ribavirin peginterferon alfa-2b

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Manns Michael P

Wedemeyer Heiner

Article Info

Journal

JAMA

Abbr.

JAMA

ISSN

1538-3598

DOI

10.1001/jama.292.23.2909

Published

2004-12-15

Pages

2909-13

Language

English

Region

United States

NLM ID

7501160

Subset

Corrections

CommentOn

PMID: 15598915

External Links

PubMed source DOI: 10.1001/jama.292.23.2909 View journal details

Analysis Services

Treatment of hepatitis C in HIV-infected patients: significant progress but not the final step.

Contact

WeChat Official Account